Production, Quality Control, Stability and Pharmacotoxicity of a Malaria Vaccine Comprising Three Highly Similar PfAMA1 Protein Molecules to Overcome Antigenic Variation.
Plasmodium falciparum apical membrane antigen 1 (PfAMA1) is a leading asexual blood stage vaccine candidate for malaria. In preparation for clinical trials, three Diversity Covering (DiCo) PfAMA1 ectodomain proteins, designed to overcome the intrinsic polymorphism that is present in PfAMA1, were pro...
Main Authors: | Bart W Faber, Stephan Hellwig, Sophie Houard, Nicolas Havelange, Jürgen Drossard, Hubert Mertens, Alexander Croon, Robin Kastilan, Richard Byrne, Nicole van der Werff, Marjolein van der Eijk, Alan W Thomas, Clemens H M Kocken, Edmond J Remarque |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2016-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC5047445?pdf=render |
Similar Items
-
Humoral immune response to mixed PfAMA1 alleles; multivalent PfAMA1 vaccines induce broad specificity.
by: Kwadwo A Kusi, et al.
Published: (2009-12-01) -
Humoral immune responses to a single allele PfAMA1 vaccine in healthy malaria-naïve adults.
by: Edmond J Remarque, et al.
Published: (2012-01-01) -
Generation of humoral immune responses to multi-allele PfAMA1 vaccines; effect of adjuvant and number of component alleles on the breadth of response.
by: Kwadwo A Kusi, et al.
Published: (2010-11-01) -
Accelerated phase Ia/b evaluation of the malaria vaccine candidate PfAMA1 DiCo demonstrates broadening of humoral immune responses
by: Edmond J. Remarque, et al.
Published: (2021-04-01) -
Efficient refolding and functional characterization of PfAMA1(DI+DII) expressed in E. coli
by: Anamika Biswas, et al.
Published: (2021-07-01)